Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT03675737
Brief Title: Pembrolizumab (MK-3475) Plus Chemotherapy Versus Placebo Plus Chemotherapy in Participants Gastric or Gastroesophageal Junction (GEJ) Adenocarcinoma (MK-3475-859/KEYNOTE-859)

First Submitted : September 17, 2018
First Submitted that Met QC Criteria : September 17, 2018
First Posted : September 18, 2018

Last Update Submitted that Met QC Criteria : April 17, 2021
Last Update Posted : April 20, 2021